Two Micro RNA’s That Trigger Tumors’ Identified

January 30, 2008 at 8:41 PM Genetics & Stem Cells News
  •   Print
  •   Share
  •   Comments
  •  Text 
“They are not in normal testis, but are expressed in testicular cancer. We see them in breast cancer cells, especially metastatic cells, but not in normal breast cells,” he added.

When the researchers established metastasis-inducing properties of the miRNAs, they started searching for their target genes in MCF-7 cells.

After many experiments, the researchers narrowed their search down to a gene called CD44, containing genetic instructions for a common cell surface receptor molecule.

CD44 is found in most cell types and affects inter-cell as well as intra-cell interactions involving their microenvironments. It may also inhibit tumor metastasis.

It was discovered that on downregulating CD44, non-metastatic MCF-7 cells became metastatic.

The researchers found that when they injected MCF-7 cells without CD44 into immunodeficient mice, the mice developed bone and lung tumors, while mice receiving MCF-7 cells with CD44 did not.

“We found that miR-373 and miR-520c interfered with the expression of CD44 in MCF-7 cells. We think there are additional targets involved, but our results suggest that these miRNAs promote cell metastasis at least in part by limiting the expression of CD44,” said Huang.

At the final level of the study, the scientists examined 11 pairs of primary and metastatic breast cancer tissue samples from cancer patients. It was discovered that metastatic tumors taken out from lymph nodes contained more miR-373 than the primary breast tumor from the same patient.

In another study of 72 human primary breast tumors, the scientists found higher mean expression of miR-373, and lower mean expression of CD44, in primary tumors from patients whose cancer had spread to their lymph nodes, as compared to patients whose tumors had not spread.

Huang said that such findings indicate that miR-373 can potentially become an important early biomarker for metastatic breast cancer.

“As far as we know, miR-373 is not expressed in normal tissue. So if we detect miR-373 in lymph nodes when a patient’s breast tumor is removed, it would indicate that cancer cells have spread and the patient will need more aggressive therapy,” said Huang.



Source-ANI
SPH/M
Previous Page 2 Page 1 | 2 
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Kidney Health Center

Genetics & Stem Cells Related News

» Genetic Traits Likely to Predispose Voters to Elect a Specific Candidate » Gene Behind Chronic Inflammation Accelerated Aging and Cancer Identified
» Discovery Of Male Fertility Genes » Disease Risk Prediction may Not be Improved by Genetic Information
» Scientists Map Gene Sequence of Drug Resistant VRSA » Marker in Premies' Saliva Predicts Readiness to Feed by Mouth
» Recovery From MS Maybe With Growth Factor In Stem Cells » 'Rare' Genetic Variants are Surprisingly Common: Report Life Scientists
Read More >>